Two Sigma Investments
ELDN icon

Two Sigma Investments’s Eledon Pharmaceuticals ELDN Stock Holding History

Two Sigma Investments’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,586
Closed -$14.5K – 3014
2023
Q2 		$14.5K Sell
10,586
-7,000
-40% -$14.6K ﹤0.01% 2930
2023
Q1 		$41.5K Sell
17,586
-4,051
-19% -$10.9K ﹤0.01% 2780
2022
Q4 		$49.3K Sell
21,637
-8,100
-27% -$20K ﹤0.01% 2594
2022
Q3 		$82K Sell
29,737
-1,400
-4% -$4.46K ﹤0.01% 2255
2022
Q2 		$76K Sell
31,137
-37,349
-55% -$114K ﹤0.01% 2299
2022
Q1 		$270K Sell
68,486
-56,707
-45% -$220K ﹤0.01% 2245
2021
Q4 		$552K Buy
125,193
+9,869
+9% +$49.9K ﹤0.01% 3153
2021
Q3 		$713K Buy
115,324
+57,814
+101% +$404K ﹤0.01% 2939
2021
Q2 		$455K Buy
57,510
+19,941
+53% +$188K ﹤0.01% 3186
2021
Q1 		$402K Buy
+37,569
New +$567K ﹤0.01% 3119

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JE
JMAC Enterprises Newtown, Pennsylvania $593M AUM 22.22% 1-Year Est. Return

Two Sigma Investments's ELDN Position: Q3 2023 in Review

Two Sigma Investments sold out of Eledon Pharmaceuticals (ELDN) in Q3 2023, closing a stake of 10,586 shares — an estimated $14.5K sold.

Two Sigma Investments first reported a position in ELDN in Q1 2021 and held it in 10 quarters. The position peaked at $713K in Q3 2021. 28 funds tracked by Wall St. Rank hold ELDN as of Q3 2023.

  • Two Sigma Investments reported no remaining Eledon Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Investments sold 10,586 Eledon Pharmaceuticals shares in Q3 2023, an estimated $14.5K.
  • Two Sigma Investments first reported a position in Eledon Pharmaceuticals in Q1 2021 and held it in 10 quarters.
  • Two Sigma Investments's Eledon Pharmaceuticals position peaked at $713K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.